Edina Shu

Early phase clinical studies of <scp>AR</scp>‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas

D. Bradley Welling, Katharine A. Collier, Sarah S. Burns et al. · Laryngoscope Investigative Otolaryngology · 2021 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

Differential perception and tolerance of chronic rhinosinusitis symptoms as a confounder of gender‐disparate disease burden

Katie M. Phillips, Regan W. Bergmark, Lloyd P. Hoehle et al. · International Forum of Allergy & Rhinology · 2019 · 20 citations

Medicine, Otolaryngology, Individual Differences +16

Validity of systemic antibiotics and systemic corticosteroid usage for chronic rhinosinusitis as metrics of disease burden

Katie M. Phillips, Marlene M. Speth, Edina Shu et al. · Rhinology Journal · 2020 · 20 citations · Full text

Medicine, Otolaryngology, Pulmonary Function Testing +12

Topical fibroblast growth factor‐2 for treatment of chronic tympanic membrane perforations

Felipe Santos, Edina Shu, Daniel J. Lee et al. · Laryngoscope Investigative Otolaryngology · 2020 · 19 citations · Full text

Medicine, Otolaryngology, Surgery +9

Assessment of Pain and Analgesic Use in Children Following Otologic Surgery

Liliya Benchetrit, Megan Kwock, Evette A. Ronner et al. · Otolaryngology · 2020 · 12 citations

Medicine, Otolaryngology, Surgery +17